Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Related Posts Investment establishes valuation of C$50M for the polymetallic Häggån project January 23, 2026 A$41M Capital Raise via Placement & Entitlement Offer January 23, 2026 Steve Barton: Silver, Gold at New Highs, Here’s What’s Cheap Right Now January 23, 2026